Roxane Desjardins

1.4k total citations
37 papers, 1.1k citations indexed

About

Roxane Desjardins is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Roxane Desjardins has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Roxane Desjardins's work include Peptidase Inhibition and Analysis (12 papers), Ubiquitin and proteasome pathways (7 papers) and Protease and Inhibitor Mechanisms (5 papers). Roxane Desjardins is often cited by papers focused on Peptidase Inhibition and Analysis (12 papers), Ubiquitin and proteasome pathways (7 papers) and Protease and Inhibitor Mechanisms (5 papers). Roxane Desjardins collaborates with scholars based in Canada, United States and France. Roxane Desjardins's co-authors include Robert Day, Frédéric Couture, Nabil G. Seidah, Kévin Ly, Anna Kwiatkowska, Annik Prat, François D’Anjou, Marie‐Claude Asselin, Christine Levesque and Peter S. McPherson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Roxane Desjardins

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxane Desjardins Canada	18	543	275	223	184	179	37	1.1k
Suryakiran Vadrevu United States	15	621 1.1×	198 0.7×	288 1.3×	91 0.5×	88 0.5×	18	1.0k
Salla Keskitalo Finland	18	960 1.8×	157 0.6×	130 0.6×	113 0.6×	169 0.9×	45	1.5k
Neil A. Taylor United Kingdom	12	580 1.1×	110 0.4×	320 1.4×	148 0.8×	179 1.0×	15	1.1k
Friedrich Fresser Austria	20	589 1.1×	133 0.5×	98 0.4×	217 1.2×	521 2.9×	36	1.3k
Richard T. Pickard United States	14	536 1.0×	171 0.6×	189 0.8×	96 0.5×	449 2.5×	20	1.3k
Juliana J. Conkright United States	13	353 0.7×	127 0.5×	86 0.4×	123 0.7×	189 1.1×	15	857
Chun‐Peng Liao United States	19	580 1.1×	96 0.3×	185 0.8×	198 1.1×	150 0.8×	31	1.1k
Rama Kamesh Bikkavilli United States	18	1.1k 2.1×	105 0.4×	142 0.6×	231 1.3×	102 0.6×	27	1.5k
Emmanuel Normant United States	22	1.3k 2.4×	160 0.6×	417 1.9×	115 0.6×	235 1.3×	50	2.0k
Alan J. Simmons United States	16	817 1.5×	226 0.8×	83 0.4×	443 2.4×	214 1.2×	34	1.3k

Countries citing papers authored by Roxane Desjardins

Since Specialization

Citations

This map shows the geographic impact of Roxane Desjardins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxane Desjardins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxane Desjardins more than expected).

Fields of papers citing papers by Roxane Desjardins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxane Desjardins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxane Desjardins. The network helps show where Roxane Desjardins may publish in the future.

Co-authorship network of co-authors of Roxane Desjardins

This figure shows the co-authorship network connecting the top 25 collaborators of Roxane Desjardins. A scholar is included among the top collaborators of Roxane Desjardins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxane Desjardins. Roxane Desjardins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kwiatkowska, Anna, et al.. (2023). Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host–Guest Inclusion Complex with β-Cyclodextrin. Molecular Pharmaceutics. 20(9). 4559–4573. 2 indexed citations

Desjardins, Roxane, et al.. (2022). Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer. Scientific Reports. 12(1). 17489–17489.

Bakrania, Anita K., et al.. (2020). Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors. Canadian Journal of Physiology and Pharmacology. 98(7). 477–481. 3 indexed citations

Kwiatkowska, Anna, Frédéric Couture, Samia Aït‐Mohand, et al.. (2019). Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug. Scientific Reports. 9(1). 2118–2118. 9 indexed citations

Couture, Frédéric, Robert Sabbagh, Anna Kwiatkowska, et al.. (2017). PACE4 Undergoes an Oncogenic Alternative Splicing Switch in Cancer. Cancer Research. 77(24). 6863–6879. 35 indexed citations

Essalmani, Rachid, Delia Susan‐Resiga, Johann Guillemot, et al.. (2017). Thrombin activation of protein C requires prior processing by a liver proprotein convertase. Journal of Biological Chemistry. 292(25). 10564–10573. 7 indexed citations

Couture, Frédéric, et al.. (2017). PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression. European Journal of Cell Biology. 96(5). 469–475. 11 indexed citations

Ly, Kévin, Rachid Essalmani, Roxane Desjardins, Nabil G. Seidah, & Robert Day. (2016). An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells. Journal of Biological Chemistry. 291(47). 24676–24687. 11 indexed citations

Duhamel, Marie, Franck Rodet, Adriana‐Natalia Murgoci, et al.. (2016). The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways. Scientific Reports. 6(1). 19360–19360. 13 indexed citations

10.

Ly, Kévin, Yascara Grisel Luna Saavedra, Maryssa Canuel, et al.. (2014). Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9. Journal of Biological Chemistry. 289(25). 17732–17746. 40 indexed citations

11.

Longuespée, Rémi, Frédéric Couture, Christine Levesque, et al.. (2014). Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target. Translational Oncology. 7(3). 410–419. 27 indexed citations

12.

Couture, Frédéric, François D’Anjou, Roxane Desjardins, François Boudreau, & Robert Day. (2012). Role of Proprotein Convertases in Prostate Cancer Progression. Neoplasia. 14(11). 1032–IN6. 51 indexed citations

13.

Gagnon, Sandra, Hugo Gagnon, Roxane Desjardins, et al.. (2012). Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion. Journal of Biological Chemistry. 287(18). 14703–14717. 33 indexed citations

14.

Levesque, Christine, Martin Fugère, Anna Kwiatkowska, et al.. (2012). The Multi-Leu Peptide Inhibitor Discriminates Between PACE4 and Furin And Exhibits Antiproliferative Effects On Prostate Cancer Cells. Journal of Medicinal Chemistry. 55(23). 10501–10511. 40 indexed citations

15.

Desjardins, Roxane, Shirley Campbell, Claude Roberge, et al.. (2011). Presence of task-1 channel in the laryngeal mucosa in the newborn lamb. Experimental Lung Research. 37(4). 205–211. 3 indexed citations

16.

Remacle, Albert G., Katarzyna Gawlik, Vladislav S. Golubkov, et al.. (2010). Selective and potent furin inhibitors protect cells from anthrax without significant toxicity. The International Journal of Biochemistry & Cell Biology. 42(6). 987–995. 33 indexed citations

17.

Poirier, Steve, Gaétan Mayer, Viviane Poupon, et al.. (2009). Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation. Journal of Biological Chemistry. 284(42). 28856–28864. 223 indexed citations

18.

Gawlik, Katarzyna, Sergey A. Shiryaev, Wenhong Zhu, et al.. (2009). Autocatalytic Activation of the Furin Zymogen Requires Removal of the Emerging Enzyme's N-Terminus from the Active Site. PLoS ONE. 4(4). e5031–e5031. 23 indexed citations

19.

Remacle, Albert G., Sergey A. Shiryaev, Eok‐Soo Oh, et al.. (2008). Substrate Cleavage Analysis of Furin and Related Proprotein Convertases. Journal of Biological Chemistry. 283(30). 20897–20906. 111 indexed citations

20.

Shiryaev, Sergey A., Albert G. Remacle, Boris I. Ratnikov, et al.. (2007). Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens. Journal of Biological Chemistry. 282(29). 20847–20853. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact